As a co-founder of Elucida Communications, Dr. Mason serves as the Chief Executive Officer and oversees all internal operations, marketing, and client relations. In addition, he uses his extensive background in research to guide the team's storytelling of complex scientific processes.

Dr. Preston Mason is a member of the Cardiovascular Division at Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts, USA. Dr Mason is also President and CEO of Elucida Research, a biotechnology research firm in Beverly, Massachusetts.  He has received many awards for his research in cardiovascular pharmacology and teaching over the past 30 years, including an honorary doctorate in science.  He received a full scholarship for graduate and medical programs (MD/PhD) at the University of Connecticut School of Medicine. Prior to coming to Boston, he was on the faculties of the University of Connecticut School of Medicine and the Medical College of Pennsylvania (now Drexel University) where he was nominated to full professor.

Dr. Mason has served on a number of grant review committees for the National Institute of Health and has been a reviewer for a number of prestigious journals. He has authored or co-authored 200 scientific articles, has multiple patents and receives frequent requests to speak at national and international conferences. As a founder of Elucida Communications, Dr. Mason serves as the Chief Executive Officer and oversees all internal operations, marketing, and client relations.